ZIOPHARM Oncology Garners $120,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f757c429-1905-4439-8567-2ad314b434f7
Date
7/8/2016
Company Name
ZIOPHARM Oncology
Mailing Address
1 First Ave. Boston, MA 02129 USA
Company Description
Operations were initiated in January 2004 with the strategy of in-licensing proprietary drug candidate families with prior related-molecule efficacy in human cancer that would be efficiently and effectively developed and commercialized by a very experienced management team supported by prominent clinicians and medical advisors.
Website
http://www.ziopharm.com
Transaction Type
Venture Equity
Transaction Amount
$120,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed